Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100669263 | 10066926 | 3 | F | 20140220 | 20140923 | 20140409 | 20140930 | EXP | PHHY2014IT039933 | SANDOZ | 49.00 | YR | F | Y | 0.00000 | 20141001 | N | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100669263 | 10066926 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | INTRAVENOUS | 420 MG, QD | D | 140124H1101 | 76959 | 420 | MG | QD | |||||
| 100669263 | 10066926 | 2 | C | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | ORAL | 1790 MG, UNK | D | 0 | 1790 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100669263 | 10066926 | 1 | Ovarian cancer |
| 100669263 | 10066926 | 2 | Ovarian cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100669263 | 10066926 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100669263 | 10066926 | Dyspnoea | |
| 100669263 | 10066926 | Feeling hot | |
| 100669263 | 10066926 | Hyperhidrosis | |
| 100669263 | 10066926 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100669263 | 10066926 | 2 | 20140130 | 20140317 | 0 |